Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Cell type, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia, Lymphoma, Myelodysplastic syndrome (MDS), Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at bezafibrate and medroxyprogesterone to treat several different blood cancers. It was for people with:
chronic lymphocytic leukaemia (CLL)
B cell
The trial was open for people to join between 2012 and 2014. The team published the results in 2019.
Recruitment start: 1 October 2012
Recruitment end: 30 June 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mark Drayson
Cancer Research UK Clinical Trials Unit Birmingham
Experimental Cancer Medicine Centre (ECMC)
Queen Elizabeth Hospital Birmingham
Queen Elizabeth Hospital Charities
University of Birmingham
Last reviewed: 10 January 2024
CRUK internal database number: 9536
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
